Asked by: Liz Jarvis (Liberal Democrat - Eastleigh)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what his Department's expected timetable is for completing consideration of reforms to the Vaccine Damage Payment Scheme; and when he expects to bring forward proposals for reform of that scheme.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
We would like to reiterate our deepest sympathies to all those individuals who have experienced harm following vaccination, and to their families.
The Government recognises that concerns have been raised in relation to the Vaccine Damage Payment Scheme. Ministers remain committed to looking at the issues raised and to considering a range of options. I will update the House in due course on progress, as appropriate.
Asked by: Liz Jarvis (Liberal Democrat - Eastleigh)
Question to the Home Office:
To ask the Secretary of State for the Home Department, what assessment her Department has made of the potential impact of the 2024–25 Health and Care Worker visa changes on access to domiciliary and residential care services; how many social care providers have had their sponsorship licences (a) suspended and (b) revoked in the past 24 months; and what proportion of those workers were left without a viable route to remain in social care employment.
Answered by Mike Tapp - Parliamentary Under-Secretary (Home Office)
The Government published the immigration white paper ‘Restoring control over the immigration system' last year which set out how we will move the UK away from a dependence on international care workers and end overseas recruitment for social care visas. The new immigration rules which prohibit overseas recruitment took effect in July 2025, however transitional arrangements exist for individuals already in the UK to switch into the route. The transitional arrangements are due to expire in 2028 but will be subject to regular review.
The Home Office continues to work closely with the Department of Health and Social Care (DHSC)-funded Regional Partnerships to support care workers, who have been impacted by exploitative employers. DHSC are funding 15 regional hubs in England, made up of Local Authorities and Directors of Adult Social Services, working together to support displaced workers into new roles within the care sector. These regional hubs have received £12.5 million this financial year to support them to prevent and respond to unethical practices in the sector.
The Government remains committed to supporting Health & Care visa holders who wish to pursue a career in the adult social care sector.
The impact assessment for the changes made in 2024 and 2025 can be found at the following links:
The Home Office does not publish revocation data broken down by business type. As a result, the specific information requested is not available within existing published statistics. Collating and verifying the relevant data solely for the purpose of this request would incur disproportionate cost.
However, the Home Office does publish general information on visa sponsors who are subject to suspension or revocation in available here: https://www.gov.uk/government/statistical-data-sets/migration-transparency-data
Asked by: Liz Jarvis (Liberal Democrat - Eastleigh)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve awareness and prevention of all strains of meningitis among students and school staff; and whether he has reviewed the adequacy of current guidelines relating to meningococcal group B.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
Meningococcal disease, both meningitis and septicaemia, is an uncommon but serious disease caused by meningococcal bacteria. The MenACWY vaccine offers good protection against several strains of meningococcal disease and is routinely offered to teenagers in school Years 9 and 10. However, it does not protect against all strains. Other strains, such as Meningitis B (MenB), can circulate among young adults. From 2015, the MenB vaccine has been available on the National Health Service as part of routine childhood immunisations, but most students would not be vaccinated.
The importance of raising awareness in parents, teenagers, and other adults about the signs and symptoms of meningitis and septicaemia remains key. There are a range of resources developed by the UK Health Security Agency (UKHSA), co-branded with the NHS, that set out these key messages and their importance, such as the teenage guide to immunisation. The guide is available at the following link:
https://www.gov.uk/government/publications/immunisations-for-young-people
The UKHSA collaboratively produces a university vaccine communications toolkit. This is shared with the distribution lists of Universities UK and the Association of Managers of Student Services in Higher Education, and is available at the following link:
In addition, United Kingdom guidance on the public health management of meningococcal disease provides clear advice on the management of confirmed and probable cases of invasive meningococcal disease, including MenB, to minimise onward transmission and further associated cases. This guidance is available at the following link:
The Department makes decisions on vaccination programmes following careful consideration of independent expert advice from the Joint Committee on Vaccination and Immunisation (JCVI). The JCVI does not currently recommend a routine MenB booster vaccination for adolescents and young adults. JCVI routinely reviews new evidence as it emerges, and my Rt. Hon. Friend, the Secretary of State for Health and Social Care, announced on 17 March that the JCVI has been asked to reexamine eligibility for meningitis vaccines. Decisions on routine vaccination programmes are taken on the basis of independent advice from the JCVI. As ever, we will carefully consider its advice.
Asked by: Liz Jarvis (Liberal Democrat - Eastleigh)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, if she will review the findings of the Spanish Data Protection Agency regarding the handling of biometric and personal data by Yoti; what safeguards are in place to help ensure that the use of Yoti complies with UK data protection law and protects users’ privacy and online safety; and what assessment she has made of the potential implications of these issues for the development and public trust in any future Government-led digital identity scheme.
Answered by Ian Murray - Minister of State (Department for Science, Innovation and Technology)
Yoti provides a range of digital identity and facial age estimation services, and its Digital ID app service is certified against the UK digital verification services trust framework. Services certified against the framework are entitled to be on a statutory register, providing the public and businesses with confidence that a service is safe, accurate and trustworthy.
Continued presence of Yoti’s service on that register should assure users of its compliance with the trust framework’s robust rules.
The department is aware of the findings of the Spanish Data Protection Agency regarding this app and has reported them to the independent conformity assessment body that certified Yoti’s service against the trust framework. If that body finds that the service isn’t following the framework, they will report the non-conformity to Yoti, which Yoti must either fix or lose their certification and registration.
If the department isn’t satisfied with the conformity assessment body’s assessment and determines that the trust framework isn’t being followed, we can remove services from the register independent of the certification process.
The Government’s digital ID scheme is currently under consultation, and any findings regarding Yoti’s service have no implications for its development.